SF Zhou, JP Liu, B Chowbay - Drug metabolism reviews, 2009 - Taylor & Francis
Pharmacogenetics is the study of how interindividual variations in the DNA sequence of specific genes affect drug response. This article highlights current pharmacogenetic …
UM Zanger, K Klein - Frontiers in genetics, 2013 - frontiersin.org
Cytochrome P450 2B6 (CYP2B6) belongs to the minor drug metabolizing P450s in human liver. Expression is highly variable both between individuals and within individuals, owing to …
DW Haas, HJ Ribaudo, RB Kim, C Tierney… - Aids, 2004 - journals.lww.com
Objectives: Efavirenz is an effective antiretroviral agent, but central nervous system side effects occur commonly, and population (racial) differences in pharmacokinetics and …
The cytochrome P450s are responsible for about 75% of phase I dependent drug metabolism and for the metabolism of a huge amount of dietary constituents and …
M Rotger, S Colombo, H Furrer, G Bleiber… - Pharmacogenetics …, 2005 - journals.lww.com
Background Efavirenz (EFV) and nevirapine (NVP) are metabolized by cytochrome P450 2B6 (CYP2B6). Allele 516 G> T (Gln172His) is associated with diminished activity of this …
Ethnopharmacological relevance Herb–drug interactions are of great concern in health practices. Curcumin is a natural polyphenol extracted from turmeric, a spice widely used all …
V Mukund, D Mukund, V Sharma, M Mannarapu… - Critical Reviews in …, 2017 - Elsevier
Genistein is an isoflavone present in soy and is known to have multiple molecular effects, such as the inhibition of inflammation, promotion of apoptosis, and modulation of steroidal …
Drug metabolism studies constitute an important and necessary step in the evaluation of drug efficacy and safety. In vivo drug metabolism studies suffer from many disadvantages …
UM Zanger, K Klein, T Saussele, J Blievernicht… - 2007 - Taylor & Francis
Polymorphisms in drug-metabolizing enzymes and drug transporters contribute to wide and inheritable variability in drug pharmacokinetics, response and toxicity. One of the less well …